- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy Forum
Archived Questions and AnswersThis Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
CCoPE
Date: 2009-06-22
Question:
I have a male patient who takes Hydroxiurea from 5 years now due to sickle cell anemia (without this drug he was undergoing continuously to hemolityc crisis). he now wants a baby but his sperm is without cells. He stopped for 4 months hydroxiurea but no sign of recovery. It is possible that he became sterile?
Answer:
Reproductive toxicity subsequent to hydroxyurea administration has been shown in male rats. Animal studies have shown alterations of sperm chromatin structure, abnormal sperm head morphology, decreased sperm density, and decreased circulating testosterone with hydroxyurea application. These effects are probably induced by the inhibition of ribonucleotide reductase and DNA synthesis leading to the depletion of meiotic daughter cells and differentiated cell types that normally produce mature sperm. Also apoptosis of germ cells appears to be increased by this agent. In human cases, a retrospective review of semen analysis from four adult men taking between 1 and 1.5 g/day of this medication for a period of 8 to 126 months, and from three of these men after cessation of therapy, it was suggested that hydroxyurea may reduce sperm count and motility and may results in abnormal morphology. One of these men with azoospermia, recovered from spermatogenesis upon the cessation of hydroxyurea treatment; however, in the other two cases sperm morphology and mobility remained impaired.












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)